Appreciation plaque unveiled at Fuhong Society of Macau's Happy Kitchen Social Enterprise

Extending company's commitment to serving community through Impact Week

MACAO, Oct. 10, 2026 /PRNewswire/ -- Coinciding with World Mental Health Day, Sands China and NBA Cares co-organised Health and Wellness Day today, the fourth event of the NBA Cares x Sands Cares Community Impact Week 2026 at the Fuhong Society of Macau's Happy Kitchen Social Enterprise (Happy Kitchen). Supported by Sands China, Happy Kitchen provides vocational training and meals to people in need in Macao. On the day of the event, a plaque unveiling ceremony was held to mark the official launch of the social enterprise's new service.

Two NBA legends—Stephon Marbury, a two-time NBA All-Star, and Cuttino Mobley— joined executives from Las Vegas Sands and Sands China, Sands Cares Ambassadors, and Fuhong members to assemble and distribute boxed lunches, delivering care and warm wishes to local elderly residents and community members in need. This initiative will benefit a total of 1,500 individuals, and underscores Sands China's commitment to serving the Macao community by leveraging the impact of an international basketball event to unite stakeholders from different sectors and give back to the community.

Following last year's Impact Week initiative, which delivered boxed lunches to local communities, Sands China has once again joined hands with the Fuhong Society of Macau during The NBA China Games this year to bring this tradition of care to Happy Kitchen, a newly established social enterprise of Fuhong. As a community canteen initiative supported by Sands China, Happy Kitchen provides vocational training and employment support for local youth with special educational needs, persons with disabilities, and individuals in mental health recovery. The initiative helps participants apply their strengths and integrate into the community, while also providing meal support to those in need. Through its support of this initiative, Sands China aims to further promote social inclusion and extend its positive impact to benefit the wider community.

During the event, representatives of Fuhong Society of Macau led guests on a tour of Happy Kitchen, introducing the social enterprise's vision, operational model, and daily operations. Subsequently, executives from Las Vegas Sands and Sands China, and Fuhong representatives officiated a plaque unveiling ceremony to mark the official launch of the social enterprise's service. This initiative underscores both parties' shared commitment to fostering social inclusion and creating equal opportunities for individuals in need to engage with society and unleash their potential.

Following the ceremony, the NBA legends, Las Vegas Sands and Sands China executives, Sands Cares Ambassadors, and Fuhong members joined forces to assemble 200 lunch boxes and deliver them to local community members. The event was filled with a joyful and warm atmosphere, as all participants demonstrated teamwork, putting their care for the Macao community into meaningful action.   

Patrick Dumont, chairman of the board and chief executive officer of Las Vegas Sands Corp., and chairman of the board and non-executive director of Sands China Ltd., said: "We sincerely thank the Central People's Government, the Macao SAR Government, and the people of Macao for their long-standing guidance and support. As an enterprise rooted in Macao, we have once again partnered with NBA Cares to extend the impact of a world-class sporting event and bring support to every corner of the local community. Serving alongside local social service organisations, we are dedicated to building more caring and impactful community services. Together with NBA legends, we have engaged with communities across Macao, extending warmth while harnessing the power of sport to bring people together and promote social inclusion. Looking ahead, Sands China remains committed to supporting local community initiatives and working together with all sectors of society to foster the diversified and inclusive development of Macao."

Grant Chum, chief executive officer and executive director of Sands China Ltd., said: "Sands China has always been committed to serving the community, and we are delighted to leverage this year's world-class NBA China Games to bring together caring efforts from across the region and join hands with the Fuhong Society of Macau to deliver boxed lunches to people in need within the city. As an inclusive platform that combines community service with vocational training, Happy Kitchen empowers people of all abilities to realise their potential and better integrate into the community.

"With the guidance of the Macao SAR Government and the continued support of all sectors of the community for Sands China's community care efforts, we are pleased to support this meaningful initiative and work together to foster a more inclusive community. Coinciding with World Mental Health Day, we are also encouraging greater awareness of physical and mental well-being through wellness workshops and interactive activities, helping foster a caring and inclusive society. Looking ahead, Sands China will continue to leverage the opportunities arising from international events in Macao, supporting the city's economic diversification while uniting partners across sectors to make a positive and lasting contribution to the community, and to jointly build a healthier and happier Macao."

Jennifer Chou, director of Fuhong Society of Macau, said: "Happy Kitchen is a social enterprise established by Fuhong Society of Macau in August this year. Through our meal service operations, we provide vocational training and work experiences for persons with disabilities, individuals in mental health recovery, and young people with special educational needs. To date, more than 30 trainees have engaged in various aspects of training, including meal preparation, food portioning, lunch box packaging, and customer service. By serving approximately 250 meals to the community each day, this initiative enables our trainees to gain practical skills and valuable experience in a real-world working environment.

"This boxed lunch and meal voucher distribution initiative, held at Happy Kitchen as part of the NBA Cares x Sands Cares Community Impact Week 2026, brought the community together through sports and wellness while extending care to those in need. The initiative also provided an opportunity for more people to recognise the capabilities, dedication and contributions of our members. By working together, corporations and social enterprises can combine resources and expertise to create more opportunities for persons with disabilities to access vocational training, gain practical work experience, and contribute to the community, building a healthier, more caring and inclusive society for all."

The event also featured a series of wellness workshops, including a singing bowl experience and drawing sessions. Guests joined members of the Sheng Kung Hui Macau Social Services Coordination Office and Bosco Youth Service Network, as well as Sands Cares Ambassadors, to take part in the workshops, engaging in creative activities and meaningful interactions that promoted mental well-being, while experiencing the warmth of care and companionship.

Guests attending Health and Wellness Day included: Kathy Behrens, president of social responsibility and player programs of NBA; NBA legends Stephon Marbury and Cuttino Mobley; Maria de Fatima Salvador dos Santos Ferreira, president of the general assembly of Fuhong Society of Macau; Lai Fai Pok, vice president of the general assembly of Fuhong Society of Macau; Wong Hou, chairman of the management committee of Fuhong Society of Macau; Patrick Dumont; Dr. Wilfred Wong, executive vice chairman of Sands China Ltd.; Grant Chum; Hubert Wang, chief operating officer of Sands China Ltd.; and Dave Sun, executive vice president and chief financial officer of Sands China Ltd. and managing director of Venetian Macau Limited.

The NBA Cares x Sands Cares Community Impact Week 2026 is taking place over five consecutive days, Oct. 7-11, featuring a diverse programme of activities focused on youth development, healthy living and community inclusion. Current NBA players and legends engage with communities across Macao, with the initiative seeking to extend the impact of the NBA sporting event into the community and enable more Macao residents to experience the positive energy and excitement generated by the world-class basketball event.

The concluding event of the Impact Week, the Community Basketball Carnival, will take place tomorrow (Oct. 11) at NBA HOUSE at Halls A and B of Cotai Expo at The Venetian^® Macao. During the event, an NBA legend and NBA coaches will participate in a basketball training session with members of Macau Special Olympics, bringing the Impact Week to a close through a sports exchange initiative that promotes social inclusion. 

NBA Cares x Sands Cares Community Impact Week 2026 is part of Sands Cares, the global corporate citizenship programme of Sands China's parent company. As an important stakeholder in the Macao community, Sands China has actively fulfilled its corporate social responsibility for more than two decades. Through the programme, the company strives to connect with and serve the community, give back to society, and work alongside different sectors to build a more vibrant and inclusive Macao community.

About Sands China Ltd.

Sands China Ltd. (Sands China or the Company) is incorporated in the Cayman Islands with limited liability and is listed on The Stock Exchange of Hong Kong Limited (HKEx: 1928). Sands China is the largest operator of integrated resorts in Macao. The Company's integrated resorts on the Cotai Strip comprise The Venetian^® Macao, The Plaza^® Macao, The Parisian^® Macao and The Londoner^® Macao. The Company also owns and operates Sands^® Macao on the Macao peninsula. The Company's portfolio features a diversified mix of leisure and business attractions and transportation operations, including large meeting and convention facilities; a wide range of restaurants; shopping malls; world-class entertainment at The Venetian Arena, The Londoner Arena, The Venetian Theatre, The Parisian Theatre, The Londoner Theatre and Sands Theatre; and a high-speed Cotai Water Jet ferry service between Hong Kong and Macao. The Company's Cotai Strip portfolio has the goal of contributing to Macao's transformation into a world centre of tourism and leisure. Sands China is a subsidiary of global resort developer Las Vegas Sands Corp. (NYSE: LVS).

For more information, please visit www.sandschina.com.

Sands Cares

A firm believer in the importance of corporate social responsibility, Sands China Ltd. engages with the local Macao community as a part of Sands Cares – the charitable giving programme of parent company Las Vegas Sands Corp. Sands Cares integrates the company's philanthropic work worldwide in four key areas: financial giving, community problem solving and collaboration, in-kind donations, and team member volunteerism.

Key areas of Sands Cares in Macao include the Sands Cares Ambassador programme for volunteering in the local community; charitable contributions to NGOs and community organisations; and sponsorship of community events.

For more information, please visit www.sands.com/sands-cares/ 

About NBA Social Impact & Inclusion and NBA Cares

NBA Social Impact & Inclusion drives change on issues facing fans and communities by advancing needed resources and proven partners. We create data-driven strategies and programming to empower colleagues to bring their best self. NBA Cares works with NBA players and teams to highlight important issues through the NBA's digital, social and broadcast channels, live events and partnerships.

Media contacts:

Corporate Communications, Sands China Ltd.
Mabel Wu
Tel: +853 8118 2268
Email: [email protected] 

Jesse Chiang
Tel: +853 8118 2054
Email: [email protected]

於澳門扶康會「樂膳廚房」舉行感謝牌揭幕儀式
籃球公益周延續關懷服務社群

澳門2026年10月10日 /美通社/ -- 適逢世界精神衛生日，金沙中國聯同NBA關懷行動（NBA Cares）今日於澳門扶康會轄下、由金沙中國支持、透過就業及膳食支援服務本澳社區有需要人士的社會企業「樂膳廚房」舉行「NBA關懷行動x金沙關懷籃球公益周2026」第四日活動「身心健康日」。活動當天亦舉行項目揭牌儀式，見證「樂膳廚房」正式投入服務。活動邀請兩位NBA傳奇球星，包括兩屆NBA全明星的斯蒂芬‧馬貝利（Stephon Marbury）及卡天奴‧莫比利（Cuttino Mobley），聯同拉斯維加斯金沙集團及金沙中國管理層、金沙中國關懷大使，以及澳門扶康會學員共同分裝及派發暖心午餐，向本澳長者及有需要人士送上關懷與祝福，將惠及1,500人。活動充分體現金沙中國與澳門同心同行的承諾，透過國際籃球盛事匯聚各界關愛力量，以實際行動回饋本澳社區。

繼去年於公益周向本澳社群送上暖心午餐，金沙中國今年再度在NBA中國賽期間攜手澳門扶康會，將這份溫暖傳統延續至他們新創立的社會企業「樂膳廚房」。作為由金沙中國支持的社區食堂項目，「樂膳廚房」為本澳有特殊教育需要青年、殘疾人士及精神復元人士等提供職業培訓及就業支援，協助他們發揮所長、融入社區，同時為社區有需要人士提供膳食支援。金沙中國期望透過支持項目發展，進一步推動社區共融，讓更多人士受惠。

活動當日，澳門扶康會代表帶領嘉賓參觀「樂膳廚房」，介紹項目的創立理念、營運模式及日常工作。其後，一眾拉斯維加斯金沙集團及金沙中國管理層，以及澳門扶康會代表主持「揭牌儀式」，見證項目正式投入服務，彰顯雙方攜手推動社區共融，為有需要人士創造更多平等參與、展現潛能的機會。

隨後，一眾NBA傳奇球星、拉斯維加斯金沙集團及金沙中國管理層、金沙中國關懷大使，以及澳門扶康會學員攜手參與分裝工作，合力完成200份暖心午餐，並親手送贈予社區人士。現場氣氛歡樂且溫馨，眾人分工合作、默契十足，以實際行動向本澳社區送暖。

拉斯維加斯金沙集團董事會主席兼行政總裁、金沙中國有限公司董事會主席兼非執行董事Patrick Dumont表示：「衷心感謝中央人民政府、澳門特別行政區政府，以及社會各界長期以來對金沙集團的悉心指導與鼎力支持。作為植根澳門的企業，我們今年再度與NBA關懷行動攜手，將世界級體育盛事的影響力延伸至澳門社區，把關愛傳遞至不同角落，並與本澳社服機構並肩合作，共同締造更美好的關愛社區服務。我們與NBA傳奇球星一同走進澳門社區、傳遞溫暖，充分彰顯體育凝聚人心、促進共融的力量。展望未來，金沙中國將繼續積極參與及支持各項社區服務項目，攜手推動澳門多元共融的社會發展。」

金沙中國有限公司行政總裁兼執行董事鄭君諾表示：「金沙中國一直秉持服務社區的精神，很高興藉今年NBA中國賽這項世界級體育盛事，凝聚跨地域的關愛力量，並聯同澳門扶康會向本澳有需要人士送上愛心午餐。扶康會轄下的 『樂膳廚房』是一個結合社區服務、職業培訓的共融平台，讓不同能力人士發揮所長、融入社群。有賴澳門特區政府一直以來的指導，以及社會各界對金沙中國社區關愛工作的支持，讓我們能夠參與並推進有關項目，攜手推動社區共融發展。適逢『世界精神衛生日』，我們亦藉由身心靈工作坊及互動交流，鼓勵社會各界關注身心健康，共同營造關愛共融、相互支持的社會氛圍。未來，金沙中國將繼續發揮國際盛事落戶澳門的優勢，助力澳門經濟適度多元發展，同時凝聚更多同行力量，持續為社區注入正向能量，共建健康澳門、幸福澳門。」

澳門扶康會總幹事周惠儀表示：「樂膳廚房是澳門扶康會於2026年8月開辦的社會企業，透過膳食服務為殘疾人士、精神復元人士及有特殊教育需要青年提供職業培訓和工作實踐機會。目前，樂膳廚房共有超過30名學員接受培訓，參與膳食製作、分菜、飯盒包裝及樓面服務等工作；每天為社區提供約250份膳食，讓學員在真實的工作環境中學習和累積經驗。是次『NBA關懷行動×金沙關懷籃球公益周2026』於樂膳廚房舉行愛心午餐及飯券派發活動，將運動、健康和社區關懷連結起來，讓更多人看見學員的工作能力和付出。企業與社會服務團體攜手合作，能夠結合雙方的資源和專業，為殘疾人士創造更多職業培訓、工作實踐及服務社區的機會，共同建設一個更健康、更關愛和更共融的社會。」

當天，活動亦特別安排一系列身心靈工作坊，包括頌缽體驗及繪畫等，邀請一眾嘉賓與聖公會澳門社會服務處及鮑思高青年服務網絡的會員，以及金沙中國關懷大使共同參與，透過創作、互動與交流放鬆身心，感受關懷與陪伴的力量。

出席「身心健康日」的嘉賓包括：NBA社會責任及球員項目總裁Kathy Behrens；NBA傳奇球星斯蒂芬‧馬貝利（Stephon Marbury）及卡天奴‧莫比利（Cuttino Mobley）；澳門扶康會會員大會主席飛迪華；會員大會副主席黎輝博；理事會主席黃濠；拉斯維加斯金沙集團董事會主席兼行政總裁、金沙中國有限公司董事會主席兼非執行董事Patrick Dumont；金沙中國有限公司行政副主席王英偉博士；行政總裁兼執行董事鄭君諾；首席營運總裁王志琪；以及行政副總裁兼財務總裁、威尼斯人澳門股份有限公司常務董事孫敏其。

「NBA 關懷行動 × 金沙關懷籃球公益周」於10月7日至11日一連五日舉行，涵蓋青年發展、健康生活及社區共融等多元活動，邀請NBA現役及傳奇球星走進社區，與本澳廣泛社群交流互動，致力將NBA體育盛事的影響力延伸至社區。是次公益周參與層面廣泛，旨在讓本澳更多市民共享世界級籃球盛事。

明日（10月11日）將於澳門威尼斯人金光會展A及B館內的NBA HOUSE 舉行公益周壓軸活動──「社區籃球嘉年華」。屆時，NBA傳奇球星及教練將與澳門特殊奧運會學員展開籃球交流，共同以體育為橋樑，推動社區共融，共同為公益周畫上圓滿句號。

「NBA關懷行動×金沙關懷籃球公益周」為母公司「金沙關懷」企業公民計劃的一部分。作為本澳社區的重要持份者，金沙中國二十多年來積極踐行企業社會責任，旨在透過計劃連結社區、服務社群，回饋社會，與各界攜手共建更具活力、共融精神的澳門社區。

關於金沙中國有限公司

金沙中國有限公司（香港聯交所：1928，「金沙中國」或「公司」）是一所於開曼群島註冊成立的有限公司及在香港聯合交易所有限公司上市的公司。金沙中國是澳門最大的綜合度假村經營商，於路氹金光大道上設有澳門威尼斯人^®、澳門百利宮、澳門巴黎人^®，以及澳門倫敦人^® 等物業項目，同時擁有及經營位於澳門半島的澳門金沙。公司旗下的各綜合度假村集合多樣化的娛樂消閒、商務設施及客運業務，包括大型會議及展覽場地、各式餐廳食肆、購物中心、於威尼斯人綜藝館、倫敦人綜藝館、威尼斯人劇場、巴黎人劇場、倫敦人劇場及金沙劇場舉行的世界級娛樂表演，以及來往港澳的金光飛航高速渡輪服務。公司在路氹金光大道的各物業發展項目，堅定並持續地為建設澳門成為世界旅遊休閒中心貢獻力量。金沙中國是全球度假村發展商拉斯維加斯金沙集團股份有限公司（紐約證券交易所：LVS）的附屬公司。

如欲索取更多相關資訊，請瀏覽網頁https://hk.sandschina.com/index.html。

「金沙關懷」計劃

金沙中國有限公司不遺餘力推動及履行企業社會責任，積極參與母公司拉斯維加斯金沙集團所設立的「金沙關懷」企業公民計劃回饋澳門社區。「金沙關懷」計劃引領集團在全球各地開展慈善工作，包括經濟援助、社區援助及合作、物資捐贈及員工參與義工活動等。

「金沙關懷」企業公民計劃在澳門的主要項目包括：在澳門社區開展義務工作的金沙中國關懷大使計劃、向非牟利機構及社會企業捐款以及社區活動贊助等。

如欲索取更多相關資訊，請瀏覽網頁https://www.sands.com/sands-cares/。

關於NBA社會影響與包容度及NBA關懷

NBA社會影響與包容部門通過整合所需資源和可靠的合作夥伴，制定數據驅動的策略和項目，以應對球迷和社區面臨的問題，影響NBA生態系統，並賦能同事以最佳狀態投入工作，推動全球範圍內的成功。NBA關懷行動與NBA球員和球隊合作，通過NBA的數字、社交媒體和電視轉播渠道、現場活動及合作夥伴關係，聚焦重要社會議題。

傳媒查詢：

金沙中國有限公司 – 企業傳訊部
胡美寶
電話：+853 8118 2268
電郵：[email protected]

鄭文軒
電話：+853 8118 2054
電郵：[email protected]

CHANGSHA, China, Oct. 10, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion") is expanding its mining machinery business and strengthening international operations. In the first half of 2026, its mining machinery business grew by more than 57.20% year on year, while company-wide international revenue rose 12.45% to RMB 15.535 billion, accounting for 57.25% of total revenue.

Zoomlion is developing its construction, agricultural and mining machinery businesses across three major global equipment markets. Its mining portfolio covers excavation, loading, haulage, crushing and screening.

Flagship models include the ZE4000G, a 400-tonne mining excavator, and the ZTE520 hybrid electric-drive mining truck, with a rated payload of 300 tonnes.

Zoomlion's mining engineering roots stretch back decades. In 1987, its predecessor, the Changsha Construction Machinery Research Institute, received a State Council award for developing a complete open-pit mining system capable of handling 10 million tonnes a year.

Zoomlion attributes the recent growth of its mining business to its focus on lowering equipment operating costs through continual product development, real-world testing and new technologies.

The company develops its equipment based on conditions in operating mines. In a previously reported six-month period, Zoomlion's research teams visited around 150 mines worldwide, identifying and addressing more than 50 technical challenges and incorporating field findings into product development.

"We calculate operating costs across the full equipment lifecycle so customers can see the economic benefit," said Wu Yuanfeng, deputy general manager of Zoomlion Mining Machinery. "Our pure-electric products can cut costs by more than 50%, and hybrid models can improve profitability by 15% or more, helping mines move toward more efficient, higher-quality operations."

Electrified mining equipment is also a growing focus for Zoomlion. Its hybrid mining trucks can cut fuel consumption by up to 40%, while its 100-tonne-class battery-electric mining trucks have logged more than 8,000 hours of stable operation. Its ZT160HEV hybrid mining truck can support up to 18 hours of continuous autonomous operation.

Zoomlion is also using automation and digital technology to improve mine productivity. The company has deployed autonomous trucks, remotely operated excavators and a system to coordinate mining fleets. At a large open-pit metal mine in northern China, the system increased average daily trips per truck by over 10%, according to Zoomlion.

The business has also gained traction across several international markets, with electrified equipment delivered to coal mines in Indonesia, open-pit mines in Argentina and projects in Ecuador and several African countries.

In the first half of 2026, Zoomlion's international revenue reached RMB 15.535 billion, up 12.45% year on year. International business accounted for 57.25% of total revenue, an increase of 1.67 percentage points from a year earlier. The company said growth in South America, Europe, Southeast Asia, Africa and East Asia outpaced its overall international growth rate.

To support its international business, Zoomlion is strengthening localized manufacturing, sales and service capabilities. As of June 30, 2026, it operated more than 30 primary business hubs, over 530 secondary and tertiary outlets, and more than 300 spare parts warehouses worldwide. Its Hungarian aerial work platform factory began production, while its German facility was expanded and upgraded into a multipurpose hub.

"Our overseas front-line operations and back-office teams are now digitally connected, enabling seamless 24-hour coordination," said Liu Jianqiang, Zoomlion's marketing director and deputy general manager of its overseas business.

The expansion of mining machinery and the continued growth of international operations are broadening Zoomlion's sources of revenue. In the first half of 2026, its mining machinery business grew by more than 57.20% year on year, while the company continued to build localized capabilities in overseas markets.

HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as monotherapy in the neoadjuvant/adjuvant (perioperative) treatment of resectable microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) colon cancer.

This marks a significant new indication for cadonilimab beyond gastric, lung, and cervical cancers, and represents the 13th Phase III/registrational study of the therapy conducted globally. Cadonilimab has moved from later-line to first-line treatment of advanced disease and is now being evaluated in the perioperative setting, further broadening its clinical footprint in immuno-oncology (IO) 2.0.

Colorectal cancer is among the malignancies with the highest incidence and mortality worldwide, with colon cancer accounting for most cases. Perioperative outcomes are a major determinant of long-term prognosis. Patients with MSI-H/dMMR colon cancer derive limited benefit from conventional perioperative chemotherapy, with pathological response rates of only approximately 7%—a persistent and significant unmet medical need.

In metastatic MSI-H/dMMR colorectal cancer, immune checkpoint inhibitors are already established as the standard of care. In localized disease, perioperative treatment holds the potential for curative intent and the prospect of durable clinical cure—an area of substantial clinical importance and patient value. While multiple exploratory studies of PD-(L)1 monoclonal antibodies in this setting have shown encouraging efficacy signals, no immunotherapy has yet been approved anywhere for the perioperative treatment of localized MSI-H/dMMR colon cancer.

MSI-H/dMMR colon cancer is highly responsive to immunotherapy due to its high tumor mutational burden and inflamed immune microenvironment. However, single-target immune checkpoint inhibitors still leave room for improved outcomes. By dual blockade of the PD-1 and CTLA-4 pathways, cadonilimab is designed to more effectively activate and sustain antitumor immune responses in the perioperative setting. This approach has the potential to increase rates of major pathological response (MPR) and pathological complete response (pCR), thereby lowering the risk of postoperative recurrence and improving long-term survival.

Supporting evidence comes from a prior Phase II study of cadonilimab monotherapy as neoadjuvant treatment in patients with MSI-H/dMMR colorectal cancer. Data presented at the 2024 ESMO Immuno-Oncology Congress showed a pathological complete response (pCR) rate of 84.6% and a major pathological response (MPR) rate of 100% among patients who proceeded to surgery, with a manageable safety profile.

As the first approved checkpoint bispecific antibody for cancer, cadonilimab has shown consistent clinical benefit across a broad range of patients, including both PD-L1-positive and PD-L1-negative individuals, in extensive real-world use and multiple Phase III trials. It is increasingly recognized as a foundational therapy in the immuno-oncology (IO) 2.0 era. Cadonilimab is currently being evaluated in 13 Phase III/registrational studies worldwide across major indications such as lung, gastric, cervical, liver and colon cancers, spanning first-line, second-line, perioperative, adjuvant and consolidation settings.

About Cadonilimab

Cadonilimab is a first-in-class PD-1/CTLA-4 bispecific antibody developed by Akeso for cancer immunotherapy. In June 2022, it received initial marketing approval from China's National Medical Products Administration (NMPA) for the treatment of patients with relapsed or metastatic cervical cancer who had progressed on or after platinum-based chemotherapy. In September 2024, cadonilimab was approved in combination with fluoropyrimidine- and platinum-based chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. In May 2025, cadonilimab plus platinum-based chemotherapy, with or without bevacizumab, was approved for the first-line treatment of persistent, recurrent, or metastatic cervical cancer.

By simultaneously targeting PD-1 and CTLA-4, cadonilimab delivers synergistic antitumor activity. It has shown robust efficacy with markedly lower toxicity and improved tolerability compared with conventional combination regimens, demonstrating potent activity across multiple tumor types independent of PD-L1 expression and offering breakthrough clinical value in immunotherapy-resistant and "cold" tumors.

To date, cadonilimab has been evaluated in more than 40 clinical studies spanning over 20 indications, including gastric, lung, liver, cervical, and pancreatic cancers. Thirteen Phase III/registrational studies are ongoing; three have met their primary endpoints; and two global Phase III/registrational trials are advancing.

About Akeso

Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world's first or best-in-class innovative biological medicines. Founded in 2012, Akeso has built a comprehensive R&D innovation ecosystem anchored by its proprietary Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform, Tissue-Smart siRNA/mRNA technology platform, and cell therapy technology platforms.

Backed by world-class GMP manufacturing facilities and a highly efficient, integrated commercialization system, Akeso has developed into a globally competitive biopharmaceutical enterprise. Leveraging its fully integrated, multi-functional platform, the Company maintains a robust pipeline of more than 50 innovative assets targeting cancer, autoimmune diseases, inflammation, metabolic disorders, and other major therapeutic areas. Of these, nearly 30 candidates have advanced into clinical trials, including 15 bispecific or multi-specific antibodies and bispecific ADCs. Eight innovative drugs are commercially available, and two additional drugs with three indications are currently under regulatory review for marketing approval.

Akeso is committed to becoming a global leader in biopharmaceuticals through efficient and breakthrough innovation in R&D, developing novel therapies that are first-in-class or best-in-class, and providing better disease solutions for patients around the world.

Forward-Looking Statements

This announcement by Akeso, Inc. (9926.HK, "Akeso") contains "forward-looking statements". These statements reflect the current beliefs and expectations of Akeso's management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso's other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the P.R. China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Akeso's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

Expanding horizons and inspiring growth through local youth engagement

MACAO, Oct. 9, 2026 /PRNewswire/ -- Sands China and NBA Cares jointly presented School Day today, the third event of the "NBA Cares x Sands Cares Community Impact Week" at Yuet Wah College, Macau. The event welcomed the return of NBA legend Mitch Richmond –– a 2002 NBA champion, six-time NBA All-Star, five-time All-NBA Team, and 2014 Basketball Hall of Fame Inductee –– to Macao, joining NBA coaches in visiting a local campus to engage with young Macao basketball players through a range of activities, including basketball skills training and cultural exchange experiences.

It was a valuable platform for teachers and students to gain insights from international basketball elites, while giving an NBA legend and coaches a firsthand look at the talent and potential of Macao's young athletes. The event underscores Sands China's long-standing commitment to the Macao community and its dedication to fostering a positive, inclusive and caring society. By bringing the impact of a premier international sporting event to the local community, the company aims to inspire positive youth development through this meaningful initiative.

School Day brought together around 600 participants, including Mitch Richmond and NBA coaches and management, alongside teachers and students from Yuet Wah College and Colégio Dom Bosco (Yuet Wah), senior management from Sands China, and the Sands Cares Ambassadors.

During the event, Mitch Richmond and NBA coaches led a dedicated basketball clinic for members of the boys' basketball teams from Yuet Wah College and Colégio Dom Bosco (Yuet Wah), who each won their division's championship in this year's Inter-School Basketball Competition in Macao. Through hands-on guidance and skills demonstrations, the basketball clinic provided precious learning opportunities for the students, inspiring and encouraging them in their pursuit of excellence.

Dr. Wilfred Wong, executive vice chairman of Sands China Ltd., said: "We would like to express our sincere gratitude to the Macao SAR government and various sectors of society for their long-standing support of our community initiatives, with special thanks to Yuet Wah College for arranging this initiative. These collective efforts provided a valuable opportunity for Macao's youth to learn from world-class sports elites. We are delighted to extend the impact of this international sporting event to a local school through School Day, leveraging the power of sports to nurture talent and foster cross-cultural exchange. This initiative not only provided young basketball players with an opportunity to enhance their basketball skills through close interactions with an NBA legend and coaches, but also inspired them to learn from the perseverance and pursuit of excellence that define world-class athletes. Today's event exemplifies Sands Cares' commitment to serving the community, fostering youth development, cultural exchange, and stronger social cohesion through meaningful engagement.

"Looking ahead, Sands China will continue to support the Macao SAR government's 'Tourism+' policy –– by drawing on international events in Macao to create more opportunities for the local community and younger generation to connect with the world and broaden their horizons, while showcasing Macao's unique appeal as a diverse and inclusive city on the global stage."

Ng Teng Kuong, principal of Yuet Wah College, said: "We are pleased to join hands with Sands China and NBA Cares to bring this meaningful campus activity to our students. The initiative provided members of our basketball team and fellow students with an invaluable opportunity to learn from an international basketball star, encouraging them to embrace a positive mindset both on and off the court. Through School Day, we brought the positive impact of an international sporting event into our school and the wider community, providing students with a unique opportunity to enhance their basketball skills, engage with world-class athletes, and expand their horizons. We sincerely thank Sands China and the NBA for their care and commitment to Macao's youth. Looking ahead, we will continue to strengthen collaboration with stakeholders across different sectors, creating more opportunities for students to engage with the wider world and unlock their full potential."

Beyond basketball exchange, the event featured meaningful cultural interactions. Students from Colégio Dom Bosco (Yuet Wah) delivered an electrifying freestyle rope-skipping performance on-site, showcasing the energy and diverse talents of Macao's youth. Accompanied by teachers and students at the school, NBA legend Mitch Richmond participated in a Chinese calligraphy session, learning firsthand the techniques of brushwork and ink application while gaining a deeper appreciation of the richness of Chinese culture. The experience fostered cultural exchange between East and West.

To further extend the positive impact, Sands China and the NBA donated basketballs and training equipment to Yuet Wah College, while establishing a new "Basketball Corner" on campus. Featuring a basketball-themed design, the space integrates areas for reading, social interaction and recreation, aiming to enrich students' campus life and extracurricular experiences while fostering a positive sporting culture.

School Day ended on a warm and cheerful note as students were presented with goodie bags assembled during the Impact Week's Tip-Off Day, conveying care and well wishes while encouraging them to pursue their dreams and challenge themselves to reach new heights.

Guests attending the School Day event included: Kathy Behrens, president of social responsibility and player programs of NBA; Wayne Chang, managing director of NBA Asia; NBA legend Mitch Richmond; Ng Teng Kuong, principal of Yuet Wah College; Iu Pek Fong, principal of Colégio Dom Bosco (Yuet Wah); Dr. Wilfred Wong, executive vice chairman of Sands China Ltd.; and Hubert Wang, chief operating officer of Sands China Ltd.

The "NBA Cares x Sands Cares Community Impact Week 2026" is taking place over five consecutive days, Oct. 7-11, featuring a diverse programme of activities focused on youth development, healthy living and community inclusion. Current NBA players and legends will engage with communities across Macao, with the initiative seeking to extend the impact of the NBA sporting event into the community and enable more Macao residents to experience the positive energy and excitement generated by the world-class basketball event.

The fourth event of Community Impact Week, Health and Wellness Day, will take place tomorrow (Oct. 10) at the Fuhong Society of Macau's Happy Kitchen Social Enterprise. During the event, an NBA legend, Sands China senior management, and Sands Cares Ambassadors will assemble and distribute boxed lunches to people in need in Macao, extending care and support to the local community.

"NBA Cares x Sands Cares Community Impact Week 2026" is part of Sands Cares, the global corporate citizenship programme of Sands China's parent company. As an important stakeholder in the Macao community, Sands China has actively fulfilled its corporate social responsibility for more than two decades. Through the programme, the company strives to connect with and serve the community, give back to society, and work alongside different sectors to build a more vibrant and inclusive Macao community.

For high resolution photos, please visit:

https://it-ezshare.sands.com.mo/exweb/share/0c0badbf-e2c9-4d1d-9f22-f5ec552cc24f

About Sands China Ltd.

Sands China Ltd. (Sands China or the Company) is incorporated in the Cayman Islands with limited liability and is listed on The Stock Exchange of Hong Kong Limited (HKEx: 1928). Sands China is the largest operator of integrated resorts in Macao. The Company's integrated resorts on the Cotai Strip comprise The Venetian^® Macao, The Plaza^® Macao, The Parisian^® Macao and The Londoner^® Macao. The Company also owns and operates Sands^® Macao on the Macao peninsula. The Company's portfolio features a diversified mix of leisure and business attractions and transportation operations, including large meeting and convention facilities; a wide range of restaurants; shopping malls; world-class entertainment at The Venetian Arena, The Londoner Arena, The Venetian Theatre, The Parisian Theatre, The Londoner Theatre and Sands Theatre; and a high-speed Cotai Water Jet ferry service between Hong Kong and Macao. The Company's Cotai Strip portfolio has the goal of contributing to Macao's transformation into a world centre of tourism and leisure. Sands China is a subsidiary of global resort developer Las Vegas Sands Corp. (NYSE: LVS).

For more information, please visit www.sandschina.com.

Sands Cares

A firm believer in the importance of corporate social responsibility, Sands China Ltd. engages with the local Macao community as a part of Sands Cares – the charitable giving programme of parent company Las Vegas Sands Corp. Sands Cares integrates the company's philanthropic work worldwide in four key areas: financial giving, community problem solving and collaboration, in-kind donations, and team member volunteerism.

Key areas of Sands Cares in Macao include the Sands Cares Ambassador programme for volunteering in the local community; charitable contributions to NGOs and community organisations; and sponsorship of community events.

For more information, please visit www.sands.com/sands-cares/.

About NBA Social Impact & Inclusion and NBA Cares

NBA Social Impact & Inclusion drives change on issues facing fans and communities by advancing needed resources and proven partners. We create data-driven strategies and programming to empower colleagues to bring their best self. NBA Cares works with NBA players and teams to highlight important issues through the NBA's digital, social and broadcast channels, live events and partnerships.

Media contacts:

Corporate Communications, Sands China Ltd.

Mabel Wu
Tel: +853 8118 2268
Email: [email protected]

Jesse Chiang
Tel: +853 8118 2054
Email: [email protected]

與青少年近距離互動交流 拓闊國際視野啟發成長

澳門2026年10月9日 /美通社/ -- 金沙中國攜手NBA關懷行動（NBA Cares）今日在澳門粵華中學舉行「NBA關懷行動 × 金沙關懷籃球公益周2026」第三日活動「校園日」，邀請NBA傳奇球星、2002年NBA總冠軍、六屆NBA全明星、五次入選All-NBA陣容，以及2014年入選籃球名人堂的米奇‧列治文（Mitch Richmond）再度來澳，聯同NBA教練走進校園，與本澳青年球員交流互動，共同投入籃球技術提升訓練及文化體驗等多元活動，為師生構建與國際籃球精英交流學習的寶貴平台，亦讓NBA球星親身感受澳門青年的體育實力；彰顯公司「金沙關懷」服務社區、推動正向及共融關愛的精神，致力將國際頂級體育盛事延伸至社區，啟迪青年正向成長。

活動當天匯聚NBA傳奇球星及教練、NBA管理層、澳門粵華中學及鮑思高粵華小學師生，以及金沙中國管理層及金沙中國關懷大使等約600人參與。期間，NBA球星米奇‧列治文及NBA教練為來自澳門粵華中學及鮑思高粵華小學、於本年度學界男子籃球決賽奪冠的成員進行籃球訓練營，透過親身指導及技術示範，為一眾青年學子帶來啟發與鼓舞。

金沙中國有限公司行政副主席王英偉博士表示：「衷心感謝澳門特區政府及社會各界對金沙中國社區工作的長期支持，並特別感謝澳門粵華中學協助籌辦是次活動，攜手為本澳青少年創造與國際級體育精英交流學習的寶貴機會。本次『校園日』將國際體育盛事延伸至澳門校園，進一步發揮體育育人及促進跨文化交流的作用。透過與NBA傳奇球星及教練近距離互動，本澳年輕球員不僅有機會精進球技，更能從世界級運動員身上學習堅毅拼搏、追求卓越的精神。是次活動體現了『金沙關懷』服務社區的精神，藉此互動互勉促進青少年發展、文化交流及社區連結。未來，金沙中國將持續支持澳門特區政府『旅遊+』施政方針，善用國際盛事落戶澳門的契機，為澳門社區及年青一代創造更多接軌世界、開拓視野的機會，並向世界展現澳門多元共融的城市魅力。」

澳門粵華中學校長吳庭廣表示：「本校十分高興能夠與金沙中國及NBA關懷行動合作，為學生帶來這次難得的校園活動。這活動讓本校的籃球隊員和學生有機會向國際級球星學習，鼓勵他們在球場內外都保持積極向上的態度。另外，這次活動成功將國際體育盛事的活力帶進社區和校園，學生在切磋球技之餘，又能與球星互相交流，對開闊他們的眼界有很大幫助。本校衷心感謝金沙中國和 NBA 團隊對本澳青少年的關心，未來我們會繼續與社會各界緊密合作，為同學創造更多接觸世界、發揮潛能的機會。」

此外，活動從體育交流延伸至文化互動，一眾鮑思高粵華小學的學生帶來精彩的花式跳繩表演，展現青春活力與多元才藝。而NBA傳奇球星米奇‧列治文則在學校師生陪同下體驗中國書法，從執筆、蘸墨到落筆，親身感受中華文化的獨特魅力，進一步促進中西文化交流與相互理解。

為延續活動帶來的正面影響，金沙中國與NBA特意向澳門粵華中學捐贈籃球及訓練器材，並於校內設立「籃球角」。該空間以籃球為主題，結合閱讀、交流及休憩功能，期望豐富學生的校園生活及課外體驗，並鼓勵青年培養正面的運動文化和團隊精神。

活動尾聲，一眾代表向在場學生送上於公益周啟動日悉心製作的愛心禮包，傳遞關懷與祝福，並勉勵他們勇敢追夢、持續挑戰自我。現場氣氛溫馨歡樂，為當天活動畫下圓滿句號。

出席「校園日」活動的嘉賓包括：NBA社會責任及球員項目總裁Kathy Behrens；NBA亞洲區董事總經理張文正；NBA傳奇球星米奇‧列治文（Mitch Richmond）；澳門粵華中學校長吳庭廣；鮑思高粵華小學校長余碧鳳；金沙中國有限公司行政副主席王英偉博士，以及首席營運總裁王志琪。

「NBA 關懷行動 × 金沙關懷籃球公益周」於10月7日至11日一連五日舉行，涵蓋青年發展、健康生活及社區共融等多元活動，邀請NBA現役及傳奇球星走進社區，與本澳廣泛社群交流互動，致力將NBA體育盛事的影響力延伸至社區，讓更多居民共享世界級籃球盛事帶來的正面影響。

明天（10月10日）將於澳門扶康會轄下社會企業「樂膳廚房」舉行公益周第四日活動「身心健康日」。屆時，NBA傳奇球星、金沙中國管理層及金沙關懷大使將聯同澳門扶康會學員，共同分裝及派發愛心午餐，為本澳有需人士送上關愛與支持。

「NBA關懷行動×金沙關懷籃球公益周」為母公司「金沙關懷」企業公民計劃的一部分。作為本澳社區的重要持份者，金沙中國二十多年來積極踐行企業社會責任，透過計劃連結社區、服務社群，回饋社會，與各界攜手共建更具活力及共融精神的澳門社區。

如欲下載相關高清圖片，請透過以下連結下載：

https://it-ezshare.sands.com.mo/exweb/share/0c0badbf-e2c9-4d1d-9f22-f5ec552cc24f

關於金沙中國有限公司

金沙中國有限公司（香港聯交所：1928，「金沙中國」或「公司」）是一所於開曼群島註冊成立的有限公司及在香港聯合交易所有限公司上市的公司。金沙中國是澳門最大的綜合度假村經營商，於路氹金光大道上設有澳門威尼斯人^®、澳門百利宮、澳門巴黎人^®，以及澳門倫敦人^® 等物業項目，同時擁有及經營位於澳門半島的澳門金沙。公司旗下的各綜合度假村集合多樣化的娛樂消閒、商務設施及客運業務，包括大型會議及展覽場地、各式餐廳食肆、購物中心、於威尼斯人綜藝館、倫敦人綜藝館、威尼斯人劇場、巴黎人劇場、倫敦人劇場及金沙劇場舉行的世界級娛樂表演，以及來往港澳的金光飛航高速渡輪服務。公司在路氹金光大道的各物業發展項目，堅定並持續地為建設澳門成為世界旅遊休閒中心貢獻力量。金沙中國是全球度假村發展商拉斯維加斯金沙集團股份有限公司（紐約證券交易所：LVS）的附屬公司。

如欲索取更多相關資訊，請瀏覽網頁https://hk.sandschina.com/index.html。

「金沙關懷」計劃

金沙中國有限公司不遺餘力推動及履行企業社會責任，積極參與母公司拉斯維加斯金沙集團所設立的「金沙關懷」企業公民計劃回饋澳門社區。「金沙關懷」計劃引領集團在全球各地開展慈善工作，包括經濟援助、社區援助及合作、物資捐贈及員工參與義工活動等。

「金沙關懷」企業公民計劃在澳門的主要項目包括：在澳門社區開展義務工作的金沙中國關懷大使計劃、向非牟利機構及社會企業捐款以及社區活動贊助等。

如欲索取更多相關資訊，請瀏覽網頁 https://www.sands.com/sands-cares/。 

關於NBA社會影響與包容度及NBA關懷

NBA社會影響與包容部門通過整合所需資源和可靠的合作夥伴，制定數據驅動的策略和項目，以應對球迷和社區面臨的問題，影響NBA生態系統，並賦能同事以最佳狀態投入工作，推動全球範圍內的成功。NBA關懷行動與NBA球員和球隊合作，通過NBA的數字、社交媒體和電視轉播渠道、現場活動及合作夥伴關係，聚焦重要社會議題。

傳媒查詢：

金沙中國有限公司 – 企業傳訊部

胡美寶                                                                
電話：+853 8118 2268                                      
電郵：     [email protected]                    

鄭文軒
電話：+853 8118 2054
電郵：[email protected]

GUANGZHOU, China, Oct. 9, 2026 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a world-leading IP-driven retailer and operation platform, today on a voluntary basis provided a business update on the latest performance of its flagship brand MINISO. The figures contained in this press release were based on the preliminary review of the Company's operational data.

Sales Performance of MINISO Chinese Mainland

Total GMV⁽¹⁾ of MINISO Chinese mainland for the three months ended September 30, 2026 ("26Q3") grew by 25%-30% year over year ("YoY"), accelerating from the first half of 2026, powered by a high-single-digit SSSG⁽¹⁾.

MINISO Chinese mainland maintained its strong momentum during the National Day holidays from October 1 to October 7, 2026, with total GMV growth of 20%-25% YoY, powered by a low-single-digit SSSG.

Sales Milestone of Proprietary IP YOYO

YOYO, MINISO's flagship proprietary IP, has generated GMV of over RMB1 billion for the first nine months of 2026 and has officially entered the global IP "One Billion Club". Since its first product launch in June 2025, YOYO has expanded into 53 countries and regions worldwide, emerging as one of the fastest Chinese original IPs to achieve large-scale global expansion. Mr. Guofu Ye, Founder, Chairman and CEO of MINISO, stated that YOYO has validated MINISO's strategic capability as a "world's leading IP operation platform", and that MINISO will empower more Chinese original IPs to scale up and accelerate in the global market.

Sales Performance of MINISO Overseas Markets

MINISO overseas markets' performance was largely in line with the Company's guidance. MINISO USA delivered a GMV growth of around 20% YoY in 26Q3. Notably, it rebounded to over 30% GMV YoY growth and positive SSSG in September 2026 bolstered by new product arrivals.

This press release was announced by the Company on a voluntary basis to inform shareholders and potential investors of the Company of the latest business update of the Company. This press release was based on the Board's preliminary review of the relevant operational data of the Company and the information currently available to the Board, and it was not based on any figures or information which have been audited or reviewed by the Company's auditors. The information contained in this press release may be subject to change and adjustment. Shareholders and potential investors of the Company should note that sales performance of IP products is subject to seasonality, marketing cycles, and the timing of new product launches and that operational data during the National Day holiday period represents a short-term snapshot and is not necessarily indicative of the Company's performance for the entire fourth quarter of 2026 or any future period. Shareholders and potential investors of the Company are advised to exercise caution when dealing in the Company's securities.

About MINISO Group

MINISO Group is a world-leading IP-driven retailer and operation platform offering immersive consumption experiences powered by value-for-money and aesthetic products featuring IP designs. Founded in 2013, the Company has established two brands, MINISO and TOP TOY. MINISO Group has built a worldwide IP ecosystem through its top licensed IPs and proprietary IPs dual-engine model. Guided by its "Life is for Fun" philosophy, it delivers engaging experiences and emotional value to consumers around the world. For more information, please visit https://ir.miniso.com/.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "may", "will", "expect", "anticipate", "aim", "estimate", "intend", "plan", "believe", "is/are likely to", "potential", "continue" or other similar expressions. Among other things, the quotations from management in this announcement, as well as MINISO's strategic and operational plans, contain forward-looking statements. MINISO may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC") and The Stock Exchange of Hong Kong Limited (the "HKEX"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about MINISO's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: MINISO's mission, goals and strategies; future business development, financial conditions and results of operations; the expected growth of the retail market and the market of branded variety retail of lifestyle products in China and globally; expectations regarding demand for and market acceptance of MINISO's products; expectations regarding MINISO's relationships with consumers, suppliers, Retail Partners, local distributors, and other business partners; competition in the industry; proposed use of proceeds; and relevant government policies and regulations relating to MINISO's business and the industry. Further information regarding these and other risks is included in MINISO's filings with the SEC and the HKEX. All information provided in this press release and in the attachments is as of the date of this press release, and MINISO undertakes no obligation to update any forward-looking statement, except as required under applicable law.

Note: 
(1) For definitions of the operating and financial metrics used in this press release, please refer to the Company's financial results announcements and annual reports.

Investor Relations Contact

MINISO Group Holding Limited
Email: [email protected]
Phone: +86 (20) 36228788 Ext.8039

This morning (9th), the HSI opened 155 pts higher. With the upswing sharpening in the afternoon session, the index closed near the day's peak at 24,211, up 425 pts or 1.79%. Main board turnover reached HKD209.199 billion. The HSCEI closed at 8,147, up 137.29 pts or 1.71%. The HSTECH closed at 4,197, up 124 pts or 3.06%.

Techs were the key drivers of the rally. TENCENT (00700.HK) closed up 3.26%; MEITUAN-W (03690.HK) spiked 3.03%; NTES (09999.HK) swelled 3.75%; BABA-W (09988.HK) rallied 2.59% after Jefferies raised its TP to HKD186; BIDU-W (09888.HK) climbed 1.04%; and KUAISHOU-W (01024.HK) advanced 5.47%.

Automakers outshone, with XIAOMI-W (01810.HK) becoming the best-performing blue chip of the day as its share price surged 9.72%. Orders locked in for SkyNomad exceeded 70,000 units within 30 days of launch. LI AUTO-W (02015.HK), BYD COMPANY (01211.HK) and GEELY AUTO (00175.HK) all mounted more than 3%. Battery giant CATL (03750.HK) closed up 3.06% after its total battery patent holdings over the past decade ranked first globally, marking the first time a Chinese company topped the list.

Among blue chips, HSBC HOLDINGS (00005.HK) rebounded 1.82%; AIA (01299.HK) soared 2.89%; LENOVO GROUP (00992.HK) recovered 1.61%; while CHINA LIFE (02628.HK) and CSPC PHARMA (01093.HK) each dived more than 2%. Goldman Sachs expected Macau's gaming EBITDA to rebound 5% QoQ in 3Q26 and favored SANDS CHINA LTD (01928.HK) and GALAXY ENT (00027.HK) to Outperform. The two stocks rallied 3.99% and 4.83% respectively. Consumers and caterers also attracted buying interest, with MENGNIU DAIRY (02319.HK), HAIDILAO (06862.HK) and LI NING (02331.HK) all up more than 3%.
~

AASTOCKS Financial News
Website: www.aastocks.com

Australian AI data center operator Firmus, backed by NVIDIA Corporation (NVDA.US), announced that it has withdrawn its Australia listing plan due to market volatility.

Firmus plans to raise USD2-3 billion through private financing and is in talks with existing investors, Bloomberg reported, citing sources.

Sources added that Firmus will explore the possibility of listing in the US in the long run.
~

AASTOCKS Financial News
Website: www.aastocks.com

• 前莫德納腫瘤轉化醫學負責人Lakshmi Srinivasan博士、前莫德納腫瘤疫苗研究及早期臨床轉化負責人Brandon Coder博士加盟雲頂新耀
• 兩位科學家的加入將進一步助力雲頂新耀mRNA產品管線的全球臨床開發，包括計劃於2026年第四季度啟動個性化腫瘤治療性疫苗EVM16 Ib期研究者發起的臨床試驗（IIT）、於2027年初在美國遞交新藥臨床試驗申請（IND），以及預計於2027年第一季度完成通用型腫瘤治療性疫苗EVM14 I期臨床研究

上海2026年10月9日 /美通社/ -- 雲頂新耀（HKEX 1952.HK）是一家專注於創新藥研發、臨床開發、製造及商業化的生物製藥公司，今日宣佈任命Lakshmi Srinivasan博士擔任高級副總裁、轉化醫學負責人，Brandon Coder博士擔任轉化科學與早期研究副總裁。此次任命將進一步強化雲頂新耀mRNA技術平台的全球研發能力與國際合作佈局。未來，公司將持續匯聚國際化頂尖人才，整合研發資源，加速全球創新戰略落地。

兩位新任高管均擁有深厚的行業經驗和專業背景，此前曾在莫德納等全球領先的生物製藥企業負責腫瘤疫苗研發，具備從早期發現到臨床轉化及臨床開發的完整實戰經驗。兩位資深科學家將在雲頂新耀管理層的領導下，圍繞公司全球mRNA的研發戰略，重點推動mRNA技術平台在美國的臨床開發及相關業務佈局，並與中國研發團隊密切協作，進一步賦能mRNA技術平台的進化。

雲頂新耀董事會主席吳以芳表示：「我們非常高興Srinivasan博士和Coder博士加入雲頂新耀。兩位資深科學家在腫瘤疫苗研發、轉化醫學及臨床開發領域擁有深厚經驗，將進一步強化公司的全球mRNA研發能力，助力推進自主mRNA技術平台及相關產品管線的全球臨床開發。此次任命體現了雲頂新耀持續匯聚全球頂尖人才、推進全球mRNA戰略的承諾。」

Lakshmi Srinivasan博士

Srinivasan博士擁有20年腫瘤免疫領域研發經驗，作為資深免疫學家，她長期致力於推動創新腫瘤免疫療法從早期發現研究走向臨床開發，在腫瘤疫苗、mRNA-LNP（脂質納米顆粒）技術、T細胞療法及轉化醫學開發等領域擁有豐富經驗，研發經驗覆蓋從臨床前研究到臨床概念驗證的多個階段。

加入雲頂新耀前，Srinivasan博士於2023年至2025年就職於莫德納（Moderna Therapeutics），曾任執行總監、腫瘤轉化醫學負責人；此前她曾任Repertoire Immune Medicines副總裁、臨床前科學與轉化醫學負責人，Neon Therapeutics（後併入BioNTech）轉化科學高級總監及賽諾菲（Sanofi）腫瘤藥物發現負責人。

Srinivasan博士長期從事個性化新抗原疫苗臨床轉化研究，並在該領域發表多篇高影響力學術論文。她作為通訊作者參與了NEO-PV-01的Ib期臨床研究，相關研究成果分別發表於《Cell》（2020年）^[1]和《Cancer Cell》（2022年）^[2]。此外，她也作為共同作者參與了莫德納 intismeran autogene（mRNA-4157/V940）的多篇代表性論文，包括發表於《Cancer Discovery》（2024年）的I期KEYNOTE-603研究中mRNA-4157/V940單藥及聯合帕博利珠單抗治療所誘導的T細胞應答^[3]；以及發表於《JCO Oncology Advances》（2026年）的mRNA-4157/V940聯合帕博利珠單抗治療切除後黑色素瘤的隨機IIb期 KEYNOTE-942研究3年隨訪結果^[4]。

Srinivasan博士曾在哈佛醫學院（Harvard Medical School）免疫疾病研究所（Immune Disease Institute）開展博士後研究，擁有印度科學研究院（Indian Institute of Science）微生物學與細胞生物學博士學位、賈瓦哈拉爾‧尼赫魯大學（Jawaharlal Nehru University）生物技術碩士學位及德裡大學（University of Delhi）生物化學學士學位。

Brandon Coder博士

Coder博士擁有超過11年的生物醫藥行業研發經驗，長期致力於推動T細胞免疫療法從早期發現研究走向IND申報及早期臨床概念驗證。他在腫瘤疫苗、mRNA/LNP平台技術及in vivo CAR療法領域擁有豐富經驗。

加入雲頂新耀前，Coder博士於2019年至2025年就職於莫德納，曾擔任莫德納腫瘤疫苗研究副科學總監等職務。在職期間，他曾是mRNA-4157/V940研究及全球藥理學負責人，並作為共同作者參與該項目KEYNOTE-603 I期臨床研究，相關研究成果發表於《Cancer Discovery》（2024年）^[3]。此外，他同時是莫德納共享抗原腫瘤疫苗mRNA-4359和mRNA-4106共享抗原發現及疫苗設計框架的共同發明人，並負責相關研發工作。

此前，Coder博士還曾任Advaxis Immunotherapies腫瘤免疫研發副總監，負責個性化及現貨型腫瘤疫苗的研發。

Coder博士擁有美國北德克薩斯大學健康科學中心（University of North Texas Health Science Center）生物醫學科學博士學位，研究方向為免疫學與遺傳學，並擁有德州理工大學（Texas Tech University）生物學學士學位。

關於雲頂新耀mRNA技術平台

作為全球少數擁有全流程、自主可控mRNA技術平台的生物製藥公司之一，雲頂新耀已構建起涵蓋抗原設計、mRNA序列優化、脂質納米顆粒（LNP）靶向遞送技術到產業化生產的完整產業鏈平台，擁有mRNA平台價值鏈端到端的能力，並成功實現臨床驗證。

雲頂新耀依托業內領先且完全整合的AI+mRNA平台，不僅可實現規模化生產，還擁有強大的知識產權組合。公司已建立並持續優化自主的LNP遞送技術平台，已在可電離脂質與隱形脂質方向形成專利群，擁有超過600種內部專有脂質分子，滿足多類型項目需求。通過自研的第三代AI算法的加持，顯著提升了mRNA的表達水平，為mRNA腫瘤疫苗的開發奠定了堅實基礎。

基於自主知識產權的AI+mRNA平台，雲頂新耀正多路徑推進mRNA腫瘤治療性疫苗和自體生成CAR-T平台，治療腫瘤及自身免疫疾病：

• 個性化腫瘤治療性疫苗EVM16完成首次人體臨床數據讀出，顯示出良好的安全性、耐受性、顯著的免疫原性及積極的初步療效信號，部分數據已於2026年美國癌症研究協會（AACR）年會上公佈。EVM16計劃於2026年第四季度啟動IIT（研究者發起的臨床試驗） Ib期臨床研究，並在Ia研究基礎上，開展新的適應症擴展隊列，進行有效性探索；並計劃於2027 H1遞交美國食品藥品監督管理局（FDA）新藥臨床試驗申請（IND）。
• 通用現貨型腫瘤相關抗原（TAA）疫苗EVM14，繼2025年相繼獲得美國FDA及中國國家藥品監督管理局「雙重IND」批准後，公司將於2027年第一季度完成臨床I期單藥劑量遞增。
• 自體生成CAR-T療法EVM18已啟動針對自身免疫疾病的IIT研究，同時公司正穩步推進其全球IND申報工作。

參考文獻

1. Ott PA, et al., A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer. Cell, 2020
2. Awad MA, et al., Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer. Cancer Cell, 2022
3. Gainor et al., T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study. Cancer Discovery, 2024
4. Carlino et al., Three-Year Update of a Randomized Phase IIb Study of the Individualized Neoantigen Therapy Intismeran Autogene (mRNA-4157, V940) Plus Pembrolizumab Versus Pembrolizumab in Resected Melanoma. JCO advances, 2026

關於雲頂新耀
雲頂新耀是一家專注於創新藥研發、臨床開發、製造和商業化的生物製藥公司，致力於滿足全球市場尚未滿足的醫療需求。雲頂新耀的管理團隊在中國及全球領先製藥企業擁有深厚的專長和豐富的經驗。公司在浙江嘉善擁有具備商業化規模的全球生產基地，並依據中國、歐盟和WHO標準建立了完善的GMP生產質量管理體系。

公司聚焦自身免疫、眼科、急重症及CKM（心血管、腎臟及代謝）等疾病治療領域，已打造集全渠道商業化體系與藥品全生命週期商業化能力於一體的商業化平台，並以擁有全球權益的自研mRNA平台為基礎，持續推進mRNA in vivo CAR-T與mRNA腫瘤疫苗等現有管線，同時通過引進及生態孵化潛力平台，拓展研發能力，同時強化全球化佈局，加快國際化發展進程。更多信息，請訪問公司官網：www.everestmedicines.com。

前瞻性聲明
本新聞稿所發佈的信息中可能會包含某些前瞻性表述，乃基於本公司或管理層在做出表述時對公司業務運營情況及財務狀況的現有看法、相信、和現有預期，可能會使用「將」、「預期」、「預測」、「期望」、「打算」、「計劃」、「相信」、「預估」、「確信」及其他類似詞語進行表述。這些前瞻性表述並非對未來業績的保證，會受到風險、不確定性及其他因素的影響，有些乃超出本公司的控制範圍，難以預計。因此，受我們的業務、競爭環境、政治、經濟、法律和社會情況的未來變化及發展等各種因素及假設的影響，實際結果可能會與前瞻性表述所含資料有較大差別。本公司及各附屬公司、各位董事、管理人員、顧問及代理未曾且概不承擔更新該稿件所載前瞻性表述以反映在本新聞稿發佈日後最新信息、未來項目或情形的任何義務，除非法律要求。